Takeda Pharmaceutical (TAK) News Today $14.72 -0.04 (-0.24%) Closing price 03:59 PM EasternExtended Trading$14.72 +0.01 (+0.03%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TAK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Buy Rating for Takeda Pharmaceutical Driven by Successful Phase 3 Trials of OveporextonJuly 15 at 5:31 AM | tipranks.comTakeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in ...July 14 at 4:32 AM | gurufocus.comTakeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1July 14 at 3:00 AM | businesswire.comTakeda: Positives And Negatives Offset Each OtherJuly 11, 2025 | seekingalpha.comVontobel Holding Ltd. Acquires New Shares in Takeda Pharmaceutical Co. (NYSE:TAK)July 9, 2025 | marketbeat.comCrossmark Global Holdings Inc. Purchases 186,349 Shares of Takeda Pharmaceutical Co. (NYSE:TAK)July 8, 2025 | marketbeat.comCallan Capital LLC Invests $735,000 in Takeda Pharmaceutical Co. (NYSE:TAK)July 8, 2025 | marketbeat.comTakeda Completes Treasury Share Disposal with Minor AdjustmentsJuly 8, 2025 | tipranks.comTakeda Pharmaceutical Co. (NYSE:TAK) Stock Position Raised by Sequoia Financial Advisors LLCJuly 1, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Reaches New 12-Month High - What's Next?June 30, 2025 | marketbeat.comSun Pharma Announces Appointment of Richard Ascroft as CEO North AmericaJune 25, 2025 | finance.yahoo.comTakeda Announces New Assignments of DirectorsJune 25, 2025 | businesswire.comTakeda Pharmaceutical Co Ltd ADR Key Metrics - MorningstarJune 24, 2025 | morningstar.comMAlagille Syndrome Market Research 2025-2035 | Competitive Analysis of Mirum Pharmaceuticals, Ipsen, and Takeda PharmaceuticalJune 24, 2025 | uk.finance.yahoo.comQuestex’s Fierce Pharma Unveils Powerhouse Conference Program for the Inaugural Fierce Pharma Week, Where Pharma’s Future Takes ShapeJune 23, 2025 | finance.yahoo.comYousif Capital Management LLC Has $444,000 Stock Position in Takeda Pharmaceutical Co. (NYSE:TAK)June 21, 2025 | marketbeat.comInscription Capital LLC Invests $303,000 in Takeda Pharmaceutical Co. (NYSE:TAK)June 19, 2025 | marketbeat.comTakeda Pharmaceutical Co. (NYSE:TAK) Shares Purchased by QRG Capital Management Inc.June 18, 2025 | marketbeat.comGAMMA Investing LLC Has $1.56 Million Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)June 15, 2025 | marketbeat.comSun Pharma names Kirti Ganorkar as new managing director, Dilip Shanghvi to continue as chairmanJune 13, 2025 | msn.comWealth Enhancement Advisory Services LLC Lowers Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)June 9, 2025 | marketbeat.comClean Yield Group Lowers Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)June 8, 2025 | marketbeat.comTakeda Reports Adcetris Combo Approved by EC for Hodgkin LymphomaJune 4, 2025 | msn.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Bought by NBC Securities Inc.June 4, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Short Interest Up 33.3% in MayJune 3, 2025 | marketbeat.comLegacy Wealth Asset Management LLC Buys 44,635 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)June 2, 2025 | marketbeat.comProtagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia VeraJune 1, 2025 | businesswire.comVersant Capital Management Inc Purchases 23,166 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)June 1, 2025 | marketbeat.comAt the WBUR Festival, exploring the good and bad scenarios for Massachusetts’ futureMay 31, 2025 | msn.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Summit Global InvestmentsMay 31, 2025 | marketbeat.comToronto Dominion Bank Takes $6.76 Million Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 31, 2025 | marketbeat.comTwo Sigma Advisers LP Increases Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 30, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Bank of America Corp DEMay 30, 2025 | marketbeat.comVoloridge Investment Management LLC Raises Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 28, 2025 | marketbeat.comForum Financial Management LP Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 27, 2025 | marketbeat.comGTS Securities LLC Makes New Investment in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 27, 2025 | marketbeat.com26,600 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Bought by Point72 Asset Management L.P.May 26, 2025 | marketbeat.com510,600 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Acquired by Toronto Dominion BankMay 24, 2025 | marketbeat.comMillennium Management LLC Sells 1,655,703 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)May 22, 2025 | marketbeat.comJanus Henderson Group PLC Has $3.10 Million Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 22, 2025 | marketbeat.comSoleus Capital Management L.P. Purchases 680,000 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)May 21, 2025 | marketbeat.comFocus Partners Wealth Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 20, 2025 | marketbeat.comQuantinno Capital Management LP Increases Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 19, 2025 | marketbeat.comDimensional Fund Advisors LP Increases Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 17, 2025 | marketbeat.com230,000 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Purchased by LMR Partners LLPMay 15, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Holdings Raised by Hudson Bay Capital Management LPMay 15, 2025 | marketbeat.comBalyasny Asset Management L.P. Invests $2.56 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 15, 2025 | marketbeat.comBNP Paribas Financial Markets Has $6.63 Million Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)May 15, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Stake Increased by Jane Street Group LLCMay 15, 2025 | marketbeat.comThe New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1May 14, 2025 | businesswire.com Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼1.290.97▲Average Medical News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼45▲TAK Articles Average Week Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News Today GSK News Today ARGX News Today ONC News Today BNTX News Today INSM News Today TEVA News Today SMMT News Today ITCI News Today GMAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TAK Stock Alerts